One mechanism involves the engulfment of tumor-derived material followed by the presentation of major histocompatibility complex (MHC) class II (MHCII)-loaded peptides to CD4+ T helper cells, which in turn engage other immune cells such as macrophages and B cells. The gene discussed is CD4; the disease is neoplasm.